Citations (118)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Michal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska & Magdalena Bujalska-Zadrozny. (2020) The Psychiatric Characteristics of People on a Mephedrone (“bath salts”) Binge. Substance Use & Misuse 55:10, pages 1610-1617.
Read now
Read now
Parvaneh Naserzadeh, Farzaneh Jokar, Farzaneh Vafaei, Enayatollah Seydi & Jalal Pourahmad. (2018) Toxicity of new synthetic amphetamine drug mephedrone On Rat Heart mitochondria: a warning for its abuse. Xenobiotica 48:12, pages 1278-1284.
Read now
Read now
Liam Roberts, Loretta Ford, Neel Patel, J. Allister Vale & Sally M. Bradberry. (2017) 11 analytically confirmed cases of mexedrone use among polydrug users. Clinical Toxicology 55:3, pages 181-186.
Read now
Read now
Anneka Varma, Neel Patel, Loretta Ford, Rachel Jones & J. Allister Vale. (2017) Misuse of 2-(ethylamino)-1-(4-methylphenyl)-1-pentanone (4-MEAP), a synthetic cathinone. Clinical Toxicology 55:3, pages 231-232.
Read now
Read now
Matilda Bäckberg, Erik Lindeman, Olof Beck & Anders Helander. (2015) Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clinical Toxicology 53:1, pages 46-53.
Read now
Read now
Fridtjof Heyerdahl, Knut Erik Hovda, Isabelle Giraudon, Christopher Yates, Alison M. Dines, Roumen Sedefov, David M. Wood & Paul I. Dargan. (2014) Current European data collection on emergency department presentations with acute recreational drug toxicity: Gaps and national variations. Clinical Toxicology 52:10, pages 1005-1012.
Read now
Read now
Michael Capriola. (2013) Synthetic cathinone abuse. Clinical Pharmacology: Advances and Applications 5, pages 109-115.
Read now
Read now
Anders Helander, Olof Beck, Robert Hägerkvist & Peter Hultén. (2013) Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA project. Scandinavian Journal of Clinical and Laboratory Investigation 73:5, pages 400-406.
Read now
Read now
Shan Yin & Mona Ho. (2012) Monitoring a toxicological outbreak using Internet search query data. Clinical Toxicology 50:9, pages 818-822.
Read now
Read now
JacobM. McClean, Ara Anspikian & JohnW. Tsuang. (2012) Bath Salt Use: A Case Report and Review of the Literature. Journal of Dual Diagnosis 8:3, pages 250-256.
Read now
Read now
David M. Wood, Fiona Measham & Paul I. Dargan. (2012) ‘Our favourite drug’: prevalence of use and preference for mephedrone in the London night-time economy 1 year after control. Journal of Substance Use 17:2, pages 91-97.
Read now
Read now
David P. Kasick, Curtis A. McKnight & Eleonora Klisovic. (2012) “Bath Salt” Ingestion Leading to Severe Intoxication Delirium: Two Cases and a Brief Review of the Emergence of Mephedrone Use. The American Journal of Drug and Alcohol Abuse 38:2, pages 176-180.
Read now
Read now
Douglas B. Murray, Stephen Potts, Carole Haxton, Gillian Jackson, Euan A. Sandilands, John Ramsey, Malgorzata Puchnarewicz, David W. Holt, Atholl Johnston, D. Nicholas Bateman & James W. Dear. (2012) ‘Ivory wave’ toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning. Clinical Toxicology 50:2, pages 108-113.
Read now
Read now
Simon L. Hill & Simon H. L. Thomas. (2011) Clinical toxicology of newer recreational drugs. Clinical Toxicology 49:8, pages 705-719.
Read now
Read now
Henry A. Spiller, Mark L. Ryan, Robert G. Weston & Joanne Jansen. (2011) Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clinical Toxicology 49:6, pages 499-505.
Read now
Read now
Articles from other publishers (103)
Gabriela Bielecka‐Papierz, Ewa Poleszak, Joanna Listos, Bernadeta Szewczyk, Aleksandra Szopa, Jolanta Orzelska‐Górka, Justyna Turek, Dorota Bederska‐Łojewska, Małgorzata Jakóbczuk, Jarosław Szponar, Sylwia Talarek & Anna Serefko. (2023)
The
L‐arginine‐NO‐cGMP
pathway mediates the locomotor activity alterations during the expression of sensitization to mephedrone in mice
. Clinical and Experimental Pharmacology and Physiology 50:8, pages 621-633.
Crossref
Crossref
Gabriela Bielecka-Papierz, Ewa Poleszak & Anna Serafko. (2023) Mephedrone – a synthetic derivative of cathinone. Current Issues in Pharmacy and Medical Sciences 36:1, pages 54-64.
Crossref
Crossref
Joyce V.B. Borba, Vinicius M. Alves, Rodolpho C. Braga, Daniel R. Korn, Kirsten Overdahl, Arthur C. Silva, Steven U.S. Hall, Erik Overdahl, Nicole Kleinstreuer, Judy Strickland, David Allen, Carolina Horta Andrade, Eugene N. Muratov & Alexander Tropsha. (2022)
STopTox: An
in Silico
Alternative to Animal Testing for Acute Systemic and Topical Toxicity
. Environmental Health Perspectives 130:2.
Crossref
Crossref
Christopher Yates & Piotr M. Kabata. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
181
202
.
Kerry Layne, Paul I. Dargan & David M. Wood. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
333
380
.
H-H Chou, C-H Hsieh, C-H Chaou, C-K Chen, T-H Yen, S-C Liao, C-J Seak & H-Y Chen. (2021) Synthetic cathinone poisoning from ingestion of drug-laced “instant coffee packets” in Taiwan. Human & Experimental Toxicology 40:9, pages 1403-1412.
Crossref
Crossref
Deborah Rudin, Matthias E. Liechti & Dino Luethi. (2021) Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Experimental Neurology 343, pages 113778.
Crossref
Crossref
Jorge Soares, Vera Marisa Costa, Maria de Lourdes Bastos, Félix Carvalho & João Paulo Capela. (2021) An updated review on synthetic cathinones. Archives of Toxicology 95:9, pages 2895-2940.
Crossref
Crossref
Owen Bowden-Jones & Dima Abdulrahim. 2020. Club Drugs and Novel Psychoactive Substances. Club Drugs and Novel Psychoactive Substances.
Máté Kapitány-Fövény, Ornella Corazza, Shanna Marrinan & Zsolt Demetrovics. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
307
325
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
295
425
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions.
Jessica Mead & Andrew Parrott. (2020) Mephedrone and MDMA: A comparative review. Brain Research 1735, pages 146740.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Xun Zhou, Dino Luethi, Gerda Sanvee, Jamal Bouitbir, Matthias Liechti & Stephan Krähenbühl. (2019) Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts. International Journal of Molecular Sciences 20:7, pages 1561.
Crossref
Crossref
Kateřina Grohmannová & Viktor Mravčík. (2018) New psychoactive substances in Europe and Czech Republic. Psychiatrie pro praxi 19:3, pages 96-100.
Crossref
Crossref
Lina Homman, Jessica Seglert & Michael J. Morgan. (2018) An observational study on the sub-acute effects of mephedrone on mood, cognition, sleep and physical problems in regular mephedrone users. Psychopharmacology 235:9, pages 2609-2618.
Crossref
Crossref
Elizabeth B. de Sousa Fernandes Perna, Eef L. Theunissen, Patrick C. Dolder, Natasha L. Mason, Nadia R. P. W. Hutten, Stefan W. Toennes, Kim P. C. Kuypers & Johannes G. Ramaekers. (2018) Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans. Frontiers in Pharmacology 9.
Crossref
Crossref
Simon L. Hill & Paul I. Dargan. 2018. New Psychoactive Substances. New Psychoactive Substances
475
494
.
Toshiyuki Matsunaga, Yoshifumi Morikawa, Miki Tanigawa, Kyohei Kamata, Akinobu Shibata, Yasuhide Sasajima, Koichi Suenami, Kiyohito Sato, Yuji Takekoshi, Satoshi Endo, Ossama El-Kabbani & Akira Ikari. (2017) Structure-activity relationship for toxicity of α-pyrrolidinophenones in human aortic endothelial cells. Forensic Toxicology 35:2, pages 309-316.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Stephen J. deRoux & William A. Dunn. (2017) “Bath Salts” the New York City Medical Examiner Experience: A 3-Year Retrospective Review. Journal of Forensic Sciences 62:3, pages 695-699.
Crossref
Crossref
S.J. Traub & M.D. Levine. 2017. Critical Care Neurology Part II. Critical Care Neurology Part II
485
505
.
Rachelle Abouchedid & David M. Wood. 2017. Critical Care Toxicology. Critical Care Toxicology
1485
1524
.
Salma M. Khaled, Elizabeth Hughes, Dan Bressington, Monica Zolezzi, Ahmed Radwan, Ashish Badnapurkar & Richard Gray. (2016) The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol. Systematic Reviews 5:1.
Crossref
Crossref
Odd Martin Vallersnes, Alison M. Dines, David M. Wood, Christopher Yates, Fridtjof Heyerdahl, Knut Erik Hovda, Isabelle Giraudon & Paul I. Dargan. (2016) Psychosis associated with acute recreational drug toxicity: a European case series. BMC Psychiatry 16:1.
Crossref
Crossref
Lewis Jones, Phil Reed & Andrew Parrott. (2016) Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users. Journal of Psychopharmacology 30:12, pages 1313-1320.
Crossref
Crossref
David M. Wood & Paul I. Dargan. 2016. Current Practice in Forensic Medicine. Current Practice in Forensic Medicine
35
46
.
Maria João Valente, Ana Margarida Araújo, Renata Silva, Maria de Lourdes Bastos, Félix Carvalho, Paula Guedes de Pinho & Márcia Carvalho. (2015) 3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions. Archives of Toxicology 90:8, pages 1959-1973.
Crossref
Crossref
David M. Wood & Paul I. Dargan. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
208
218
.
Simon Elliott. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
94
126
.
Michael D. BerquistIIII, Haily K. Traxler, Alyssa M. Mahler & Lisa E. Baker. (2016) Sensitization to the locomotor stimulant effects of “bath salt” constituents, 4‐methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats. Drug and Alcohol Dependence 164, pages 128-134.
Crossref
Crossref
Elli Tyrkkö, Mikael Andersson & Robert Kronstrand. (2016) The Toxicology of New Psychoactive Substances. Therapeutic Drug Monitoring 38:2, pages 190-216.
Crossref
Crossref
Igor Linhart, Michal Himl, Monika Židková, Marie Balíková, Eva Lhotková & Tomáš Páleníček. (2016) Metabolic profile of mephedrone: Identification of nor-mephedrone conjugates with dicarboxylic acids as a new type of xenobiotic phase II metabolites. Toxicology Letters 240:1, pages 114-121.
Crossref
Crossref
Rachelle Abouchedid & David M. Wood. 2016. Critical Care Toxicology. Critical Care Toxicology
1
40
.
Esther Papaseit, José Moltó, Robert Muga, Marta Torrens, Rafael de la Torre & Magí Farré. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
313
331
.
Alexandra Maas, Cornelia Wippich, Burkhard Madea & Cornelius Hess. (2015) Driving under the influence of synthetic phenethylamines: a case series. International Journal of Legal Medicine 129:5, pages 997-1003.
Crossref
Crossref
Blake A. Froberg, Michael Levine, Michael C. Beuhler, Bryan S. Judge, Philip W. Moore, Kristin M. Engebretsen, Nathanael J. Mckeown, Christopher D. Rosenbaum, Amy C. Young & Daniel E. Rusyniak. (2014) Acute Methylenedioxypyrovalerone Toxicity. Journal of Medical Toxicology 11:2, pages 185-194.
Crossref
Crossref
John R. Richards, Timothy E. Albertson, Robert W. Derlet, Richard A. Lange, Kent R. Olson & B. Zane Horowitz. (2015) Treatment of toxicity from amphetamines, related derivatives, and analogues: A systematic clinical review. Drug and Alcohol Dependence 150, pages 1-13.
Crossref
Crossref
Ana Margarida Araújo, Maria João Valente, Márcia Carvalho, Diana Dias da Silva, Helena Gaspar, Félix Carvalho, Maria de Lourdes Bastos & Paula Guedes de Pinho. (2014) Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of ‘legal high’ packages containing synthetic cathinones. Archives of Toxicology 89:5, pages 757-771.
Crossref
Crossref
Mohsen Vazirian, Jason M. Jerry, Jeffrey James & Roman M. Dale. (2015) Bath Salts in the Emergency Department. Journal of Addiction Medicine 9:2, pages 94-98.
Crossref
Crossref
Michael D. Berquist, M. Melissa Peet & Lisa E. Baker. (2015) Behavioral sensitization following concurrent exposure to mephedrone and D-amphetamine in female mice. Behavioural Pharmacology 26:1 and 2 - Special Issue, pages 180-183.
Crossref
Crossref
Hanna Uosukainen, Ulrich Tacke & Adam R. Winstock. (2015) Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users. International Journal of Drug Policy 26:1, pages 78-83.
Crossref
Crossref
Piotr Adamowicz, Dariusz Zuba & Bogumiła Byrska. (2014) Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB). Forensic Science International 245, pages 126-132.
Crossref
Crossref
Ana de Castro, Elena Lendoiro, Hadriana Fernández-Vega, Stefan Steinmeyer, Manuel López-Rivadulla & Angelines Cruz. (2014) Liquid chromatography tandem mass spectrometry determination of selected synthetic cathinones and two piperazines in oral fluid. Cross reactivity study with an on-site immunoassay device. Journal of Chromatography A 1374, pages 93-101.
Crossref
Crossref
Enrico Gerace, Michele Petrarulo, Fabrizio Bison, Alberto Salomone & Marco Vincenti. (2014) Toxicological findings in a fatal multidrug intoxication involving mephedrone. Forensic Science International 243, pages 68-73.
Crossref
Crossref
Kristyn Tekulve, Andreia Alexander & Laura Tormoehlen. (2014) Seizures Associated With Synthetic Cathinone Exposures in the Pediatric Population. Pediatric Neurology 51:1, pages 67-70.
Crossref
Crossref
D. M. Wood, S. L. Hill, S. H. L. Thomas & P. I. Dargan. (2014) Using poisons information service data to assess the acute harms associated with novel psychoactive substances. Drug Testing and Analysis 6:7-8, pages 850-860.
Crossref
Crossref
A R Green, M V King, S E Shortall & K C F Fone. (2014) The preclinical pharmacology of mephedrone; not just MDMA by another name. British Journal of Pharmacology 171:9, pages 2251-2268.
Crossref
Crossref
Matthew L. Banks, Travis J. Worst, Daniel E. Rusyniak & Jon E. Sprague. (2014) Synthetic Cathinones (“Bath Salts”). The Journal of Emergency Medicine 46:5, pages 632-642.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging drugs of abuse. Disease-a-Month 60:3, pages 110-132.
Crossref
Crossref
Nicolas Hohmann, Gerd Mikus & David Czock. (2014) Effects and Risks Associated with Novel Psychoactive Substances. Deutsches Ärzteblatt international.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging Drugs of Abuse. Emergency Medicine Clinics of North America 32:1, pages 1-28.
Crossref
Crossref
Xiaoqing Li, Cornelius E. Uboh, Lawrence R. Soma, Ying Liu, Fuyu Guan, Craig R. Aurand, David S. Bell, Youwen You, Jinwen Chen & George A. Maylin. (2014) Sensitive hydrophilic interaction liquid chromatography/tandem mass spectrometry method for rapid detection, quantification and confirmation of cathinone-derived designer drugs for doping control in equine plasma. Rapid Communications in Mass Spectrometry 28:2, pages 217-229.
Crossref
Crossref
Richard A. Glennon. 2014. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse
581
620
.
Maria João Valente, Paula Guedes de Pinho, Maria de Lourdes Bastos, Félix Carvalho & Márcia Carvalho. (2013) Khat and synthetic cathinones: a review. Archives of Toxicology 88:1, pages 15-45.
Crossref
Crossref
Janice E. Sullivan & Mark J. McDonald. 2014. Pediatric Critical Care Medicine. Pediatric Critical Care Medicine
695
727
.
Kilak Kesha, Cassie L. Boggs, Mary G. Ripple, Carol H. Allan, Barry Levine, Rebecca Jufer-Phipps, Suzanne Doyon, PaoLin Chi & David R. Fowler. (2013) Methylenedioxypyrovalerone (“Bath Salts”),Related Death: Case Report and Review of the Literature,. Journal of Forensic Sciences 58:6, pages 1654-1659.
Crossref
Crossref
Aymeric Petit, Laurent Karila, Michel Sananes & Michel Lejoyeux. (2013) La méphédrone : une nouvelle drogue de synthèse. La Presse Médicale 42:10, pages 1310-1316.
Crossref
Crossref
. 2013. Brain Disorders in Critical Illness. Brain Disorders in Critical Illness
329
418
.
Jolanta B. Zawilska & Jakub Wojcieszak. (2013) Designer cathinones—An emerging class of novel recreational drugs. Forensic Science International 231:1-3, pages 42-53.
Crossref
Crossref
Karen Miotto, Joan Striebel, Arthur K. Cho & Christine Wang. (2013) Clinical and pharmacological aspects of bath salt use: A review of the literature and case reports. Drug and Alcohol Dependence 132:1-2, pages 1-12.
Crossref
Crossref
J. Martínez-Clemente, R. López-Arnau, M. Carbó, D. Pubill, J. Camarasa & E. Escubedo. (2013) Mephedrone pharmacokinetics after intravenous and oral administration in rats: relation to pharmacodynamics. Psychopharmacology 229:2, pages 295-306.
Crossref
Crossref
Nicholas F. Dybdal-Hargreaves, Nicholas D. Holder, Paige E. Ottoson, Melanie D. Sweeney & Tyisha Williams. (2013) Mephedrone: Public health risk, mechanisms of action, and behavioral effects. European Journal of Pharmacology 714:1-3, pages 32-40.
Crossref
Crossref
Kenji Tsujikawa, Toshiyasu Mikuma, Kenji Kuwayama, Hajime Miyaguchi, Tatsuyuki Kanamori, Yuko T. Iwata & Hiroyuki Inoue. (2012) Identification and differentiation of methcathinone analogs by gas chromatography‐mass spectrometry. Drug Testing and Analysis 5:8, pages 670-677.
Crossref
Crossref
Fazlin Mohd Fauzi, Alexios Koutsoukas, Andrew Cunningham, Ana Gallegos, Roumen Sedefov & Andreas Bender. (2013)
Computer‐aided (
in silico
) approaches in the mode‐of‐action analysis and safety assessment of Ostarine and 4‐methylamphetamine
. Human Psychopharmacology: Clinical and Experimental 28:4, pages 365-378.
Crossref
Crossref
John M. Stogner & Bryan Lee Miller. (2013) Investigating the ‘bath salt’ panic: The rarity of synthetic cathinone use among students in the United States. Drug and Alcohol Review, pages n/a-n/a.
Crossref
Crossref
Anders Just Pedersen, Lotte Ask Reitzel, Sys Stybe Johansen & Kristian Linnet. (2012)
In vitro
metabolism studies on mephedrone and analysis of forensic cases
. Drug Testing and Analysis 5:6, pages 430-438.
Crossref
Crossref
Erik W. Gunderson, Matthew G. Kirkpatrick, Laura M. Willing & Christopher P. Holstege. (2013) Substituted Cathinone Products. Journal of Addiction Medicine 7:3, pages 153-162.
Crossref
Crossref
Christine M. Murphy, Anna R. Dulaney, Michael C. Beuhler & Sherri Kacinko. (2012) “Bath Salts” and “Plant Food” Products: the Experience of One Regional US Poison Center. Journal of Medical Toxicology 9:1, pages 42-48.
Crossref
Crossref
SE Shortall, AR Green, KM Swift, KCF Fone & MV King. (2013) Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia. British Journal of Pharmacology 168:4, pages 966-977.
Crossref
Crossref
Mathias B. Forrester. (2013) Adolescent Synthetic Cathinone Exposures Reported to Texas Poison Centers. Pediatric Emergency Care 29:2, pages 151-155.
Crossref
Crossref
Piotr Adamowicz, Bogdan Tokarczyk, Roman Stanaszek & Markus Slopianka. (2013) Fatal Mephedrone Intoxication—A Case Report. Journal of Analytical Toxicology 37:1, pages 37-42.
Crossref
Crossref
Osama I.G. Khreit, M. Helen Grant, Tong Zhang, Catherine Henderson, David G. Watson & Oliver B. Sutcliffe. (2013) Elucidation of the Phase I and Phase II metabolic pathways of (±)-4′-methylmethcathinone (4-MMC) and (±)-4′-(trifluoromethyl)methcathinone (4-TFMMC) in rat liver hepatocytes using LC–MS and LC–MS2. Journal of Pharmaceutical and Biomedical Analysis 72, pages 177-185.
Crossref
Crossref
David M. Wood & Paul I. Dargan. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
211
231
.
Frank T. Peters & Markus R. Meyer. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
131
157
.
Markus R. Meyer & Frank T. Peters. (2012) Analytical Toxicology of Emerging Drugs of Abuse—An Update. Therapeutic Drug Monitoring 34:6, pages 615-621.
Crossref
Crossref
David M. Wood & Paul I. Dargan. (2012) Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39:2, pages 227-233.
Crossref
Crossref
Rebekah Brennan & Marie Claire Van Hout. (2012) Miaow miaow: a review of the new psychoactive drug mephedrone. Drugs and Alcohol Today 12:4, pages 241-253.
Crossref
Crossref
Mariarosaria Aromatario, Edoardo Bottoni, Mariangela Santoni & Costantino Ciallella. (2012) New “Lethal highs”: A case of a deadly cocktail of GHB and Mephedrone. Forensic Science International 223:1-3, pages e38-e41.
Crossref
Crossref
Renata Lisek, Wei Xu, Ekaterina Yuvasheva, Yi-Ting Chiu, Allen B. Reitz, Lee-Yuan Liu-Chen & Scott M. Rawls. (2012) Mephedrone (‘bath salt’) elicits conditioned place preference and dopamine-sensitive motor activation. Drug and Alcohol Dependence 126:1-2, pages 257-262.
Crossref
Crossref
Suzan Owaisat, Robert B. Raffa & Scott M. Rawls. (2012) In vivo comparison of harmine efficacy against psychostimulants: Preferential inhibition of the cocaine response through a glutamatergic mechanism. Neuroscience Letters 525:1, pages 12-16.
Crossref
Crossref
D. M. Wood & P. I. Dargan. (2012) Understanding How Data Triangulation Identifies Acute Toxicity of Novel Psychoactive Drugs. Journal of Medical Toxicology 8:3, pages 300-303.
Crossref
Crossref
David M. Wood & Paul I. Dargan. (2012) Novel Psychoactive Substances. Therapeutic Drug Monitoring 34:4, pages 363-367.
Crossref
Crossref
K. G. Shanks, T. Dahn, G. Behonick & A. Terrell. (2012) Analysis of First and Second Generation Legal Highs for Synthetic Cannabinoids and Synthetic Stimulants by Ultra-Performance Liquid Chromatography and Time of Flight Mass Spectrometry. Journal of Analytical Toxicology 36:6, pages 360-371.
Crossref
Crossref
M. Coppola & R. Mondola. (2012) Research chemicals marketed as legal highs: The case of pipradrol derivatives. Toxicology Letters 212:1, pages 57-60.
Crossref
Crossref
Josh Mugele, Kristine A. Nañagas & Laura M. Tormoehlen. (2012) Serotonin Syndrome Associated With MDPV Use: A Case Report. Annals of Emergency Medicine 60:1, pages 100-102.
Crossref
Crossref
M. Martin, J.F. Muller, K. Turner, M. Duez & V. Cirimele. (2012) Evidence of mephedrone chronic abuse through hair analysis using GC/MS. Forensic Science International 218:1-3, pages 44-48.
Crossref
Crossref
Marie Claire Van Hout & Tim Bingham. (2012) “A Costly Turn On”: Patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors. International Journal of Drug Policy 23:3, pages 188-197.
Crossref
Crossref
L. Ramoz, S. Lodi, P. Bhatt, A.B. Reitz, C. Tallarida, R.J. Tallarida, R.B. Raffa & S.M. Rawls. (2012) Mephedrone (“bath salt”) pharmacology: insights from invertebrates. Neuroscience 208, pages 79-84.
Crossref
Crossref
David M. Wood, Malgorzata Puchnarewicz, Atholl Johnston & Paul I. Dargan. (2011) A case series of individuals with analytically confirmed acute diphenyl-2-pyrrolidinemethanol (D2PM) toxicity. European Journal of Clinical Pharmacology 68:4, pages 349-353.
Crossref
Crossref
Jennifer A Fass, Andrea D Fass & Angela S Garcia. (2012) Synthetic Cathinones (Bath Salts): Legal Status and Patterns of Abuse. Annals of Pharmacotherapy 46:3, pages 436-441.
Crossref
Crossref
Osama I.G. Khreit, Craig Irving, Elke Schmidt, John A. Parkinson, Niamh Nic Daeid & Oliver B. Sutcliffe. (2012) Synthesis, full chemical characterisation and development of validated methods for the quantification of the components found in the evolved “legal high” NRG-2. Journal of Pharmaceutical and Biomedical Analysis 61, pages 122-135.
Crossref
Crossref
Jane M. Prosser & Lewis S. Nelson. (2011) The Toxicology of Bath Salts: A Review of Synthetic Cathinones. Journal of Medical Toxicology 8:1, pages 33-42.
Crossref
Crossref
Harry Meng, James Cao, Jiesheng Kang, Xiaoyou Ying, Junzhi Ji, William Reynolds & David Rampe. (2012) Mephedrone, a new designer drug of abuse, produces acute hemodynamic effects in the rat. Toxicology Letters 208:1, pages 62-68.
Crossref
Crossref
M. Coppola & R. Mondola. (2012) 3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicology Letters 208:1, pages 12-15.
Crossref
Crossref
M. Perrin, Y. Lecompte, O. Roussel, R. Le Boisselier, J. Bourgine & A. Coquerel. 2012. Traité De Toxicologie Médico-judiciaire. Traité De Toxicologie Médico-judiciaire
507
547
.
J Kehr, F Ichinose, S Yoshitake, M Goiny, T Sievertsson, F Nyberg & T Yoshitake. (2011) Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. British Journal of Pharmacology 164:8, pages 1949-1958.
Crossref
Crossref
Guillermo Burillo-Putze, Alberto Domínguez-Rodríguez, Pedro Abreu-González & Santiago Nogué Xarau. (2011) Khat, mefedrona y dolor torácico. Medicina Clínica 137:15, pages 712-713.
Crossref
Crossref
Matthew D. Cook. (2011) Clean But Not Sober. Pediatric Emergency Care 27:9, pages 892-894.
Crossref
Crossref
A.D. Shah, D.M. Wood & P.I. Dargan. (2011) Survey of ICD-10 coding of hospital admissions in the UK due to recreational drug toxicity. QJM: An International Journal of Medicine 104:9, pages 779-784.
Crossref
Crossref
Eman Y. Santali, Anna-Karina Cadogan, Niamh Nic Daeid, Kathleen A. Savage & Oliver B. Sutcliffe. (2011) Synthesis, full chemical characterisation and development of validated methods for the quantification of (±)-4′-methylmethcathinone (mephedrone): A new “legal high”. Journal of Pharmaceutical and Biomedical Analysis 56:2, pages 246-255.
Crossref
Crossref
Paul I. Dargan, Roumen Sedefov, Ana Gallegos & David M. Wood. (2011) The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Testing and Analysis 3:7-8, pages 454-463.
Crossref
Crossref